PERSISTENCE WITH ANTI-TUMOR NECROSIS FACTOR THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN ROUTINE PRACTICE

被引：1
|
作者：
Morel, J. [1 ]
Combe, B. [1 ]
Daien, C. [1 ]
Lukas, C. [1 ]
机构：
[1] Teaching Hosp Lapeyronie, Rheumatol, Montpellier, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0571
引用
收藏
页码：867 / 867
页数：1
相关论文
共 50 条
  • [21] EFFECTIVENESS AND PERSISTENCE OF THE FIRST TUMOR NECROSIS FACTOR INHIBITOR IN PORTUGUESE PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, R.
    Rocha, T. M.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, G.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    VALUE IN HEALTH, 2017, 20 (09) : A527 - A527
  • [22] Thromboembolic events and anti-tumor necrosis factor therapies
    Masson, P. L.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 14 (04) : 444 - 445
  • [23] Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis
    Xu, Zhenhua
    Vu, Thuy
    Lee, Howard
    Hu, Chuanpu
    Ling, Jie
    Yan, Hong
    Baker, Daniel
    Beutler, Anna
    Pendley, Charles
    Wagner, Carrie
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1056 - 1070
  • [24] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Martin Rudwaleit
    Filip Van den Bosch
    Martina Kron
    Sonja Kary
    Hartmut Kupper
    Arthritis Research & Therapy, 12
  • [25] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Rudwaleit, Martin
    Van den Bosch, Filip
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (03)
  • [26] TUMOUR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, A. R.
    Martins Rocha, T.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, C.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1584 - 1585
  • [27] Rapid Resolution of Erosive Psoriatic Juvenile Idiopathic Arthritis With Anti-Tumor Necrosis Factor Therapy
    Felix, Mario David
    Ostrov, Barbara E.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) : S688 - S689
  • [28] Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis
    Guidelli, Giacomo Maria
    Tenti, Sara
    Fioravanti, Antonella
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (02): : 187 - U101
  • [29] Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor α agents in rheumatoid arthritis
    Sokka, T
    Pincus, T
    ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 313 - 318
  • [30] Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
    Mazzoccoli, Gianluigi
    Notarsanto, Incoronata
    de Pinto, Gennaro Davide
    Dagostino, Mariangela Pia
    De Cata, Angelo
    D'Alessandro, Giuseppe
    Tarquini, Roberto
    Vendemiale, Gianluigi
    INTERNAL AND EMERGENCY MEDICINE, 2010, 5 (06) : 495 - 500
12345